As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated analysis of skin lesions. The initial implementation of DERM began in Romania ...
A health tech company and Dr. Kevin Wong, founder of PT Family Medicine, partner to bring advanced, non-invasive skin cancer evaluation to rural Penn Trafford. MIAMI ...
H. Peter Soyer is a shareholder of MoleMap NZ Limited and e-derm consult GmbH and undertakes regular teledermatological reporting for both companies. He is a Medical Consultant for Canfield Scientific ...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, lipid-lowering drugs, were associated with a 22% lower risk for nonmelanoma skin cancer (NMSC) in patients with atherosclerotic ...
Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback